Treatment strategies in recurrent esophageal or junctional cancer after neoadjuvant therapy followed by esophagectomy

MLA

Sjoerd M. Lagarde, et al. “Treatment Strategies in Recurrent Esophageal or Junctional Cancer after Neoadjuvant Therapy Followed by Esophagectomy.” Journal of Clinical Oncology, vol. 33, May 2015, p. e15024. EBSCOhost, https://doi.org/10.1200/jco.2015.33.15_suppl.e15024.

APA

Sjoerd M. Lagarde, Suzanne S. Gisbertz, Rogier Butter, Hanneke W. M. van Laarhoven, Maarten C.C.M. Hulshof, Sybren L. Meijer, Maarten C. J. Anderegg, Jacques J. Bergman, & Mark I. van Berge Henegouwen. (2015). Treatment strategies in recurrent esophageal or junctional cancer after neoadjuvant therapy followed by esophagectomy. Journal of Clinical Oncology, 33, e15024. https://doi.org/10.1200/jco.2015.33.15_suppl.e15024

Chicago

Sjoerd M. Lagarde, Suzanne S. Gisbertz, Rogier Butter, Hanneke W. M. van Laarhoven, Maarten C.C.M. Hulshof, Sybren L. Meijer, Maarten C. J. Anderegg, Jacques J. Bergman, and Mark I. van Berge Henegouwen. 2015. “Treatment Strategies in Recurrent Esophageal or Junctional Cancer after Neoadjuvant Therapy Followed by Esophagectomy.” Journal of Clinical Oncology 33 (May): e15024. doi:10.1200/jco.2015.33.15_suppl.e15024.